CA2398226A1 - Comprime de nelfinavir a dose elevee et methode de production connexe - Google Patents

Comprime de nelfinavir a dose elevee et methode de production connexe Download PDF

Info

Publication number
CA2398226A1
CA2398226A1 CA002398226A CA2398226A CA2398226A1 CA 2398226 A1 CA2398226 A1 CA 2398226A1 CA 002398226 A CA002398226 A CA 002398226A CA 2398226 A CA2398226 A CA 2398226A CA 2398226 A1 CA2398226 A1 CA 2398226A1
Authority
CA
Canada
Prior art keywords
nelfinavir
tablet
mixture
binder
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002398226A
Other languages
English (en)
Inventor
Grace Chen
James L. Gallagher
Yosyong Surakitbanharn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CA2398226A1 publication Critical patent/CA2398226A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
CA002398226A 2002-01-28 2002-08-15 Comprime de nelfinavir a dose elevee et methode de production connexe Abandoned CA2398226A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35142002P 2002-01-28 2002-01-28
US60/351,420 2002-01-28

Publications (1)

Publication Number Publication Date
CA2398226A1 true CA2398226A1 (fr) 2003-07-28

Family

ID=27663002

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002398226A Abandoned CA2398226A1 (fr) 2002-01-28 2002-08-15 Comprime de nelfinavir a dose elevee et methode de production connexe

Country Status (23)

Country Link
EP (1) EP1469836A1 (fr)
JP (1) JP2005521661A (fr)
KR (1) KR20040079952A (fr)
CN (1) CN1713895A (fr)
AR (1) AR038236A1 (fr)
BR (1) BR0307190A (fr)
CA (1) CA2398226A1 (fr)
GT (1) GT200300016A (fr)
HN (1) HN2003000048A (fr)
HU (1) HUP0500512A2 (fr)
IL (1) IL162724A0 (fr)
MX (1) MXPA04007237A (fr)
NI (1) NI200300001A (fr)
NO (1) NO20043238L (fr)
NZ (1) NZ533283A (fr)
PA (1) PA8564301A1 (fr)
PE (1) PE20030730A1 (fr)
PL (1) PL373882A1 (fr)
RU (1) RU2004123206A (fr)
SV (1) SV2004001467A (fr)
TW (1) TW200302111A (fr)
WO (1) WO2003063837A1 (fr)
ZA (1) ZA200404367B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008053276A1 (fr) * 2006-10-30 2008-05-08 Collette Nv Pièce de transition pour le transfert de poudre ou de matière granulaire depuis une ouverture de déversement vers une chaîne de convoyage et procédé de transfert de poudre ou de matière granulaire
MX2010002438A (es) * 2007-09-03 2010-03-30 Lucent Technologies Inc Metodo y sistema para verificar automaticamente el estado de conectividad de un enlace de protocolo de internet en una red de protocolo de internet.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6499984B1 (en) * 2000-05-22 2002-12-31 Warner-Lambert Company Continuous production of pharmaceutical granulation
MXPA03009971A (es) * 2001-05-03 2004-02-12 Hoffmann La Roche FORMA DE DOSIFICACIoN FARMACEUTICA DE MESILATO DE NELFINAVIR AMORFO.

Also Published As

Publication number Publication date
NI200300001A (es) 2004-12-21
RU2004123206A (ru) 2005-04-20
PE20030730A1 (es) 2003-08-28
CN1713895A (zh) 2005-12-28
PA8564301A1 (es) 2003-09-05
SV2004001467A (es) 2004-05-07
HUP0500512A2 (hu) 2005-09-28
EP1469836A1 (fr) 2004-10-27
IL162724A0 (en) 2005-11-20
NO20043238L (no) 2004-08-02
BR0307190A (pt) 2004-11-03
ZA200404367B (en) 2006-05-31
NZ533283A (en) 2006-12-22
MXPA04007237A (es) 2004-10-29
KR20040079952A (ko) 2004-09-16
AR038236A1 (es) 2005-01-05
TW200302111A (en) 2003-08-01
WO2003063837A1 (fr) 2003-08-07
PL373882A1 (en) 2005-09-19
JP2005521661A (ja) 2005-07-21
GT200300016A (es) 2003-09-11
HN2003000048A (es) 2003-10-28

Similar Documents

Publication Publication Date Title
KR100634253B1 (ko) 초강력 붕해제를 사용한 고속-용해 에파비렌즈 캡슐 또는정제 및 그의 제조 방법
RU2181590C2 (ru) Фармацевтические композиции, содержащие ирбесартан
KR100792389B1 (ko) 발사르탄의 고형 경구제형
JP4616009B2 (ja) ＮＳＡＩＤｓおよびトリプタンを含有する多層剤型
EP1027037B1 (fr) Preparation pharmaceutique comprenant du clodronate en tant que principe actif et de la cellulose microcristalline silicifiee en tant qu'excipient
EP0814771B1 (fr) Ameliorations concernant des compositions organiques
RU2153337C2 (ru) Таблетка парацетамола и домперидона с пленочным покрытием
KR20040044990A (ko) 구강내 붕해성 발데콕시브 조성물
SK18062002A3 (sk) Pevné orálne farmaceutické kompozície obsahujúce valsartan
WO2005082329A2 (fr) Procede de preparation de formes posologiques solides de valsartan et d'hydrochlorthiazide
CA2398226A1 (fr) Comprime de nelfinavir a dose elevee et methode de production connexe
AU761750B2 (en) Method for producing medicaments from plant extracts, in a solid form of administration
AU2003239460A1 (en) Increased-dosage nelfinavir tablet and method of making same
RU2287338C2 (ru) Способ получения таблеток из сухого экстракта зверобоя
US20050042279A1 (en) Pharmaceutical formulation comprising more than 15% tamoxifen
RU2190403C1 (ru) Фармацевтическая композиция, обладающая антибактериальным действием, и способ ее получения
EP3900708A1 (fr) Composition médicale à libération prolongée contenant du zaltoprofène
KR100589483B1 (ko) 아목시실린 및 클라불란산 또는 그의 염의 혼합물 함유분산정제 및 그의 제조방법
ZA200105098B (en) A method for producing pharmaceuticals from plant extracts in solid forms of application.
MXPA01005140A (en) Method for producing medicaments from plant extracts, in a solid form of administration
KR20050010843A (ko) 활성 성분을 지속 방출시키는, 옥스카바제핀 함유약제학적 조성물
MXPA00002290A (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued